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http:WHAT THIS PAPER ADDS
Type I Takayasu arteritis (TA) is a progressive inﬂammatory disease involving the aortic arch and its main
branches. If untreated, patients may develop hemiplegia or die at a young age. However, few reports have
focused on endovascular recanalization of the carotid artery in patients with TA. This study reports results of a
series of endovascular revascularizations for complete occlusion of the carotid artery in high risk TA patients.Objectives: Type I Takayasu arteritis is a progressive inﬂammatory disease involving the aortic arch and its main
branches. If untreated, patients may develop a variety of serious conditions ranging from hemiplegia to death.
Whilst there is a relatively strong evidence base for the outcome of surgical techniques, few reports have focused
on revascularization using an endovascular technique in patients with Takayasu arteritis.
Methods: From May 2007 to March 2013, 11 consecutive patients with Takayasu arteritis presenting with severe
cerebral ischemia symptoms caused by occlusive lesion in carotid artery underwent elective revascularization, 10
on the left carotid artery and 1 on the right. All patients received immunosuppressive treatment pre-and post-
operation. Contraindications to open surgery included: ESR >40 mm/h; ipsilateral cerebral infarction of <2
weeks duration and sufﬁcient poor health whereby the patient cannot tolerate general anesthesia. Quality of life
was analyzed using the EQ-5D questionnaire before and after surgery.
Results: Patients were followed for a mean of 31.627.4 months. Seven cases of total occlusion and 2 cases of
severe stenosis were recanalized successfully and experienced clinical remission. Recanalization failed in 2
patients, both of whom had occlusion of a long segment of the artery. Initial endovascularization comprised small
diameter, low pressure dilatation only to allow time for the reopened arteries to respond. If clinically indicated,
repeat angioplasty with a larger diameter balloon was performed 1-3 months later. Major complications occurred
in 2 patients. Eight of the recanalized carotid arteries were patent at the end of follow-up and patients had
satisfactory quality of life
Conclusions: In patients with Takayasu arteritis, carotid artery recanalization via endovascular surgery combined
with immunosuppressive therapy is effective and can be performed safely and repeatedly. The improvement in
carotid artery blood ﬂow supplying the central nervous system relieves symptoms of cerebral ischemia and is
associated with an improved quality of life.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Takayasu arteritis (TA) is a disease of unknown etiology that
may result in signiﬁcant morbidity and premature mortality
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//dx.doi.org/10.1016/j.ejvs.2015.01.018the occlusive pathological changes in the supra-aortic ves-
sels that occur with TA can cause cerebral ischemia or
infarction, visual disturbance, pulseless syndrome, and hy-
pertension.2 A delay in the diagnosis and treatment of TA,
or failure of vascular intervention is likely to lead to poor
patient outcomes.3 Currently there is no appropriate stan-
dard therapy, although immunosuppressive drugs are the
treatment of choice,4,5 and previous reports have shown
that surgical bypass can be performed safely and effectively
to treat tissue ischemia. However, percutaneous trans-
luminal angioplasty (PTA) offers a less invasive, more cost-
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lesions in patients with TA.3,6,7
Steno-occlusive disease is the primary pathologic state of
TA, especially in the left subclavian and carotid arteries,
which if untreated may result in hemiplegia or death.1e3
Traditional open surgical revascularization treatments have
demonstrated excellent long-term durability for supra-aortic
bypass procedures. But the techniques are more complex
and associated with signiﬁcant operative morbidity.8e10 As
PTA offers a minimally invasive option, techniques for ste-
notic lesions have undergone rapid development in recent
years. However, PTA is rare in situations of total occlusion
because of inability to cross the lesion with a wire. The risk
of a range of serious complications including cerebral
hemorrhage, embolism, hyperperfusion, and vascular
trauma during revascularization of multiple arch vessels
impairs adoption of the technique. There are only a few
case reports of endovascular revascularization of carotid,
brachiocephalic, and subclavian artery lesions in TA. The
purpose of this study was to report the results of a series
aiming to achieve palliation of cerebral symptoms by
endovascular revascularization for complete occlusion of
the carotid artery in high risk TA patients.MATERIALS AND METHODS
The clinical records of 11 patients with TA who received
endovascular revascularization by angioplasty between May
1, 2007 and March 30, 2013 were studied. Records included
details of disease presentation, medical history, physical
observations, diagnostic and laboratory test results, oper-
ative records, post-operative complications, and mortality.
Complete follow up was deﬁned as data obtained up to
March 30, 2013.
TA was diagnosed according to criteria of the American
College of Rheumatology.11 All patients underwent cerebral,
thoracic, and abdominal angiography to deﬁne the location
and extent of the disease. Patients were divided into clinical
types according to the Lupi-Herrera classiﬁcation.
Endovascular revascularization was provided for all ce-
rebral ischemia patients who were reluctant to undergo
traditional open surgery or who were in a critical condition
and could not meet the standard for open surgery. Con-
traindications for carotid artery revascularization were: ESR
>40 mm/h; ipsilateral cerebral infarction <2 weeks dura-
tion; and a patient too acutely ill to tolerate general anes-
thesia. The revascularization procedure was considered
successful if angiography showed patency in the carotid
artery irrespective of the vessel caliber. Success was deﬁned
by improvement of the manifestations of cerebral ischemia,
such as reduction of headache, improvement of vision, and
disappearance of dizziness.
The major target vessel for revascularization was the
carotid artery, which could be occluded in segments or
throughout its length. Carotid artery patency was deter-
mined by the results of the last imaging study, including
ultrasonic duplex imaging, computed tomography, or angi-
ography. All patients were treated with glucocorticoid andantiplatelet drugs for at least 2 weeks before and after
revascularization.12 In addition, four patients received
immunosuppressive therapy with cyclophosphamide or
methotrexate.
Femoral artery access was obtained using standard
catheterization techniques. During the procedure, 80 U/kg
of heparin was administered with an additional 15U/kg of
heparin per 1.5 hours. Angioplasty of the aortic arch was
performed with multiple angiographic projections to
determine the vestigial structure of the carotid artery. A
0.035-inch hydrophilic guide wire (Terumo, Japan) was
slowly advanced over the ostium of the carotid artery
assisted by a 4F VER catheter (Cordis Corporation, USA).
Once adequate backup had been achieved, a 0.018 inch
control wire (Boston Scientiﬁc, USA) was substituted to
cross the occlusions. If the true lumen was recanalized, or
the wire arrived at the carotid bifurcation, a 0.014 inch
PILOT/150 ﬂoppy wire (Abbott Laboratories, USA) was used
and ﬁxed in the internal or external carotid artery. A 2e3.5
mm/120 mm Amphirion DEEP balloon (Invatec, Italy) was
inﬂated to a nominal pressure for 3 minutes. Continued
vessel stenosis was regarded as an indication for further
balloon dilatation.
All patients were managed in the intensive care unit for
overnight hemodynamic and neurological monitoring, and
control of systolic blood pressure. Methylprednisolone and
heparin were administered continuously by intravenous
pump or through an indwelling carotid artery catheter for
48e72 hours. Activated coagulation time of whole blood
was maintained between 50 and 60 seconds. The dose of
corticosteroid was at ﬁrst doubled, then returned to the
pre-surgical level. If the ﬁbrinogen level and platelet count
were both higher than normal, low dose warfarin (INR 1.5e
1.8) was given. Aspirin and clopidogrel were continued after
successful intervention.
The study endpoints were death linked to TA, acute ce-
rebral ischemia or life threatening cerebral hemorrhage,
and recurrence of symptoms or clinical deterioration after
surgery. Follow up clinical examinations were performed at
6 month intervals and life table analysis was used to assess
the safety of the revascularization procedure. The EQ-5D
questionnaire was used as an index for the analysis of
health related quality of life. Scores before and 3e6 months
after the procedure were recorded and analyzed by paired t
test. The study received approval from the research ethics
board of Xuanwu Hospital.
RESULTS
Patient characteristics
All patients were diagnosed with TA based on American
College of Rheumatology criteria and included 10 females
and one male with a median age of 28.9  13.8 years
(mean 23.5 years; range 12e58 years) (Table 1). Seven
patients (64%) were admitted with hemiplegia, six cases on
the right side and one on the left, and four (36%) were
becoming comatose because of acute cerebral ischemia. All
patients had suffered from symptoms such as headache,
Table 1. General conditions, angiographic characteristics, procedures and follow up data.
Case
no.
Age/sex Symptom Involved artery Angioplasty procedure and
results
Corticosteroid and
immunosuppressive agent
Follow up
OCL STE
1 12/F Headache, vertigo,
dizziness, visual
disturbance
BCA, LC, LS LC was recanalized using 3
mm/100 mm balloon,
symptoms improved
immediately. Thrombosis 3
days post-operatively.
Prednisone 20 mg qd for 10
months, increased to 55 mg
qd and methotrexate 15 mg
qw 1 week before operation.
Continued post-operatively.
3 days (ED)
2 23/F Coma, right sided
hemiplegia
LC, LS BCA LC was recanalized by 3 mm/
40 mm balloon.
Brachiocephalic artery
angioplasty 1 month later
using 8 mm/40 mm balloon
and 10 mm/25 mm bare
stent. Able to engage in
housework.
Prednisone 30 mg qd for 3
months pre-operatively;
20 mg qd for 12 months post-
operatively, then 20 mg qod
for 12 months.
Lost at 24
months
3 22/F Severe headache,
dizziness, visual
disturbance,
memory loss
LC, LS, RS LC, LS, RS recanalized using
3.5 mm/120 mm, 3.5/
100 mm (twice) balloons.
Angioplasty three times. LS
distal left vertebral artery
occlusion at last follow up.
Patient can take part in
normal work.
Prednisone 30 mg qd for 12
months and 15 mg qd for 12
months, then
methylprednisolone 2 mg/
6 mg qod for 48 months.
72 months
4 24/F Headache, TIA LS LC LC angioplasty using 3.5 mm/
120 mm balloon. Headache
relieved.
Prednisone 20 mg qd for 3
months pre-operatively, 12
months post-operatively.
Lost at 12
months
5 27/F Coma, dizziness,
hypoposia, right
sided hemiplegia
LC, LS, RS RC,
BCA
LC recanalized by 2.5 mm/
120 mm balloon. Patient can
engage in housework after 12
months; became pregnant
but underwent a termination.
Blindness developed.
Prednisone 15 mg qd for 48
months. Cyclophosphamide
50 mg tid for 6 months.
72 months
6 44/F Headache, visual
disturbance,
memory loss
LS LC LC recanalized with 4 mm/
20 mm balloon. Stenosis
dilated about 50%, LS failed
to open. Headache lessened
and can take part in normal
work.
Prednisone 20 mg qd for 24
months. Cyclophosphamide
400 mg IV qw for 10 months.
64 months
7 23/F Coma, right sided
hemiplegia
LC, LS Failed to recanalize LC, open
surgery 3 weeks later.
Symptoms relieved, able to
engage in housework. Died of
cerebral hemorrhage at 10
months.
Prednisone 45 mg qd for 1
month before operation,
decreased to 15 mg qd for 10
months.
10 months
8 58/F Headache,
hypoposia
LC LS LC recanalized using 2 mm/
120 mm balloon once.
Headache relieved.
Prednisone 15 mg qd for 2
months post-operatively.
20 months
9 38/M Dizziness, aphasia,
right sided
hemiplegia
LC, LS Bypass from ascending aorta
to LC and LS, 4 year patency.
LC recanalized by 2.5 mm/
120 mm, 3 mm/120 mm, 3.5
mm/120 mm, 4 mm/40 mm
balloon four times.
LS and left vertebral artery
recanalized by 2.5 mm/
120 mm once.
LS occluded 3 months later.
Patient can engage in
housework.
Prednisone 20 mg qd for 48
months. Prednisone 20 mg/
qd with cyclophosphamide
600 mg IV qw for 6 months
(during 1e3 angioplasty).
Prednisone 10e15 mg qd
with leﬂunomide 20 mg qd
for 16 months (during 4e5
angioplasty).
26 months
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Table 1-continued
Case
no.
Age/sex Symptom Involved artery Angioplasty procedure and
results
Corticosteroid and
immunosuppressive agent
Follow up
OCL STE
10 18/F Headache,
dizziness, visual
disturbance, TIA
LC, RC LS, RS LS, RS angioplasty using 2.5
mm/120 mm balloon.
Failed to recanalize LC.
Symptoms relieved for 6
months but returned.
Prednisone 50 mg qd for 3
months (during angioplasty),
then prednisone 35 mg qd
with methotrexate 5 mg qd
for 6 months. Prednisone 15
e2 0 mg qd for 9 months
18 months
(ED)
11 23/F Coma, left sided
hemiplegia
RC, RICA RS, BCA RC recanalized using 2.5 mm/
120 mm, RS angioplasty by 6
mm/40 mm balloon.
Three months later, 3 mm/
100 mm balloon was used for
angioplasty in RC.
Angioplasty performed twice.
Symptoms relieved, able to
engage in housework.
Methylprednisolone 40 mg
qd for 3 months (during ﬁrst
angioplasty), then
methylprednisolone 16 mg
qd with methotrexate 10 mg
qw for 3 months (during
second angioplasty).
6 months
BCA, brachiocephalic artery; ED, endpoint events; IV, intravenous; LC, left common carotid artery; LS, left subclavian artery; M, male; OCL,
occlusion; qd, once daily; qod, once every other day; qw, once weekly; RC, right common carotid artery; RICA, right internal carotid artery;
RS, right subclavian artery; STE, stenosis; TIA, transient ischemic attack.
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interval between the onset of symptoms and diagnosis
ranged from 10 days to 26 years. Arteriographic examina-
tions were performed when the patient’s condition was
stable. The imaging demonstrated that all lesions were type
I according to the Lupi-Herrera classiﬁcation.
The affected vessels were the left common carotid artery
and subclavian artery. There was: diffuse or complete left
carotid occlusion in eight patients and multifocal severe
stenosis (>95%) in two; complete occlusion of the left
subclavian artery in nine patients, and two cases of severe
stenosis; complete occlusion in the right common carotid
artery in two patients, with one of the two having complete
occlusion in her right internal carotid artery, accompanied
by moderate stenosis in her left common carotid artery.
Other lesions included three cases of occlusion or severe
stenosis of the right subclavian artery, and three cases of
severe stenosis of the brachiocephalic artery (Table 2).Table 2. Procedures performed per vessel.
Vessel Occlusion or stenosis Recanalization
for totally
occluded vessel
Occlusion Stenosis
(>80%)
Successful Failed
Brachiocephalic artery 0 3 0 0
Left carotid artery 8 1 6 2
Right carotid artery 2 1 1 1
Left subclavian artery 9 2 2 1
Right subclavian artery 2 2 1 0Procedures and follow up
All patients were followed up for 6-72 months, except for
one whose totally occluded carotid artery was recanalized
successfully, but re-occluded by thrombosis 3 days later. The
patient’s guardians refused further surgical treatment and
she was discharged and lost to follow up.
Revascularization was successful and cerebral blood ﬂow
was restored in seven patients who had total occlusion of
the carotid artery, and in two patients who had local severe
carotid artery stenosis. All these patients reported relief of
symptoms, such as reduction of headache, improvement of
vision, disappearance of dizziness, etc. Revascularization
failed in two patients with total occlusion of the carotid
artery. Of these, one patient underwent successful
ascending aorta to left carotid artery and subclavian artery
bypass 1 month later, but died of cerebral hemorrhage 10
months after the bypass procedure. The second patientunderwent bilateral subclavian and bilateral vertebral artery
angioplasty with marked symptom relief, and is still being
monitored.Life table analysis
Ten patients were included in life table analysis. One pa-
tient (patient 7) who underwent bypass surgery was
excluded. The cumulative percentages of patients who did
not experience an endpoint event were 90% at 12 months,
and 76% at 24 months.Quality of life analysis
Quality of life analysis using the EQ-5D questionnaire was
performed on nine patients. One patient was followed up
for less than 3 months and the patient who underwent
bypass chose not to participate. Eight patients who un-
derwent direct revascularization and one who underwent
indirect revascularization (i.e. in whom revascularization of
the left carotid artery failed but dilation of the bilateral
subclavian and vertebral arteries succeeded) were included.
Health related quality of life scores were signiﬁcantly
improved 3e6 months after the operation compared with
those before (p ¼ .01).
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The mean follow up period for the 10 surviving patients was
31.6  27.4 months. The cumulative percentage of patients
who did not experience an endpoint event was 76%. Two
patients were lost to follow up, one at 24 months and the
other at 12 months. All of the eight carotid arteries that
underwent revascularization maintained patency to the end
of follow up, and the patients enjoyed a better quality of
life. One female patient had a normal pregnancy during
follow up, but chose to be induced early because of the
teratogenic effects of immunosuppressive therapy. Eight
patients remained free from serious complications such as
shock, transient ischemic attack, hemorrhage, post-
operative infection, or death during the peri-operative
and follow up periods.DISCUSSION
During the later stages of TA progression, the neurological
manifestations are often associated with steno-occlusive
vascular lesions in the arteries to the brain. These mani-
festations may include headache, dizziness, visual distur-
bance, stroke, and even premature death.13 Type I lesions
are an important cause of cerebral ischemia which is most
often associated with obstructive lesions of multiple arch
and cervical vessels. One report suggested that type I le-
sions are the most common type in the Chinese population
and standard surgical treatment is revascularization by
traditional surgery or endovascular technique.3e6,14 Diffuse
and multifocal occlusive lesion involvement of arch vessels
in TA makes traditional surgical revascularization much
more complex. Although long-term durability of open sur-
gery is excellent, the treatment is associated with signiﬁcant
cardiac, pulmonary, infectious, and neurological operative
morbidity. Endovascular techniques offer a less invasive,
more cost-effective, repeatable method for relief of
ischemia caused by stenotic lesions in TA patients. However,
carotid angioplasty in TA is technically challenging. The
experience has mostly come from treatment of stenotic
rather than occlusive lesions of the carotid artery. Potential
complications of recanalization include vascular trauma,
thromboembolism, hyperperfusion, and life threatening
bleeding, which can result in serious adverse events. Ce-
rebral hyperperfusion syndrome usually occurs several days
after CEA and is often associated with severe hypertension.
Intracerebral hemorrhage represents the most devastating
manifestation of hyperperfusion syndrome that can occur
after CEA. Unlike atherosclerotic carotid disease, the lesions
of TA are longer, less readily amenable to endarterectomy,
and cause symptoms by thrombosis rather than embolism.
Thus, common carotid bypass is performed for stroke pre-
vention and is one of the most common procedures per-
formed for ischemic disease.1 Although the exact incidence
of cerebral hyperperfusion syndrome after recanalization in
the patient with TA is unclear, the risk of hyperperfusion
and intracerebral hemorrhage remains. Thus, a revascular-
ization procedure is considered successful if angiography
shows patency in the carotid artery, irrespective of vesselcaliber. The results of 11 consecutive cases of TA treated by
endovascular revascularization for occlusion of the carotid
artery are reported. The results are encouraging, with se-
vere cerebral ischemia being prevented in 76% of patients
and a signiﬁcant improvement in health related quality of
life. Revascularization of the carotid artery by endovascular
treatment was well maintained during the follow up period
of 6-72 months, and the patients were stable without
developing new or aggravated neurological manifestations.
Neurological manifestations such as headache, dizziness,
visual disturbance, and stroke indicated serious ischemia of
the central nervous system, which is a signiﬁcant predictor
of mortality.13 Prompt interventional revascularization is
intended to prevent further organ damage, which is asso-
ciated with a poor prognosis.14 However, vascular compli-
cations were more likely when biological inﬂammation is
observed during the surgical procedure. It is preferable to
avoid traditional surgery during the active phase as aneu-
rysm formation, graft dehiscence and occlusion, and infec-
tion are more common.3e6,8,9,12,13,15 There are strict
requirements that patients must meet before traditional
open surgery can be performed. Carotid bypass has been a
mainstay in the treatment of complications associated with
Takayasu’s disease. However, carotid bypasses in patients
with TA should originate from the aortic arch rather than
from a branch of it, because the arch is typically less
involved with disease. Moreover, a number of patients with
TA were juveniles, and carotid bypass is not suitable for
juveniles. The endovascular technique is minimally invasive,
with a lower risk of surgical complications.16 The advances
in endovascular techniques have made angioplasty feasible
for stenotic arterial lesions in some high risk or urgent sit-
uations in patients with TA,3,8e10 but control of active dis-
ease is an important factor in inﬂuencing prognosis.
Because of the poor correlation between laboratory
ﬁndings and inﬂammatory activity, reliance has been placed
on clinical presentation, course of disease, and angiographic
ﬁndings to determine disease phase, as described in the
National Institutes of Health guidelines.17 In this series, only
two patients were regarded to be in a quiescent phase. All
the patients were treated with glucocorticoid and anti-
platelet drugs for at least 2 weeks before endovascular
intervention. The steroid therapy should last for at least 6
months to control the inﬂammation. The patients in this
series were able to have endovascular revascularization
with a relatively short pre-operative delay, whereas meeting
the strict requirements for traditional surgical treatment
would have meant waiting more than 3e6 months.
With regards to the technique, revascularization of the
carotid artery, which may have long-standing occlusion, is
challenging.18 The initial entry to the occluded vessel is the
most critical step. Of 11 cases, in only three could the
stump of the occluded carotid artery in the arch be found.
In the other eight cases, it was not easy to ﬁnd the right
position to penetrate. However, once the guide wire had
made a good start at the ostium, it was easier to recanalize
a TA occluded artery than a completely occluded athero-
sclerotic lesion. The pathophysiology of the two types of
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eccentric or asymmetric plaque occlusion, whereas a TA
associated lesion is concentric, symmetrical, and non-
ulcerated. Therefore, passing the wire in the center of the
stump or remnant is crucial for a successful procedure.
As the carotid artery occlusion extends from the ostium
to the bifurcation, the tapered 0.018 inch wire must be
handled with extreme dexterity to pass it through the oc-
clusion with the tip straight. Good indications of success
include when the short occluded segment is unblocked by a
gentle probing by the wire, or when low resistance is felt as
the wire crosses the occluded vessel. Complete vessel
perforation was rare, but even minor intimal injury may
lead to dissection. This was the cause of failure to recanalize
the completely occluded carotid artery in two cases.
Balloon angioplasty was performed with a 2e3.5 mm/
120 mm balloon under nominal pressure for 3 minutes. The
revascularization procedure was considered successful if
angiography showed patency in the carotid artery. Repeat
balloon dilatation was not performed during the initial
operation.
Further angioplasty treatment in a stepwise fashion
should be performed at least 1e3 months later to minimize
the possibility of unpredictable complications, such as local
dissection and thrombosis. Some reports show that angio-
plasty and stent placement in TA can be performed with
excellent immediate results.18,19 For them, the majority
were limited to short focal stenotic lesions with no com-
plete occlusions. Larger diameter balloons, cutting balloons,
and stents should be avoided routinely because of their
intense or chronic stimulation of the arteritis. The patency
and the management of re-stenosis are the most difﬁcult
issues to be faced in stenting treatment in the future.20,21
A major concern in recanalization of an occluded carotid
artery is the possibility of distal embolism, which couldFigure 1. Patient 1 was a 12 year old girl who could not stand or wa
carotid and subclavian artery occlusions (white arrow). (B) Left carotid
ﬂow (black arrows). Blood supply to the left anterior and middle cereoriginate from the stump or the lumen.2,3 Analogous
techniques used in revascularization of atherosclerotic ca-
rotid occlusions can cause distal emboli and protection
devices are used with the aim of preventing this. In this
series, no protection devices were used, although arterial
irregularity from debris could be seen after revasculariza-
tion. However, this irregular debris disappeared when
angiography was performed 3 days post-operatively and no
distal cerebral artery embolism was found in any of the
patients. Gradually increasing dilatation in a stepwise
fashion was preferred to prevent a sudden increase in
antegrade ﬂow, with the risk of ﬂushing an embolus to a
distal site. Hyperperfusion is another concern after revas-
cularization of an occluded carotid artery because of the
risk of brain swelling or hemorrhage.22 Long-term cortico-
steroid treatment can make arteries highly fragile, which
could result in rupture of vessels under high pressure.23
Most of the patients had suffered from a recent cerebral
infarction, which placed them at high risk for hemorrhagic
stroke.24 Therefore, balloon size was strictly limited during
angioplasty and blood pressure was carefully controlled
during the procedure. Fortunately, none of the patients
experienced hyperperfusion or central nervous system
hemorrhage.
Additionally coagulation disorders and thrombus forma-
tion are recognized as having an important role in the
pathogenesis of TA.3 This is because of platelet and coag-
ulation activity being signiﬁcantly increased, leading to a
hypercoagulable state with its increased risk of thrombosis.
The increase in ﬁbrinogen and platelet count in most the
patients suggests that a hypercoagulable state is a feature
of TA. Current experience obtained from carotid artery
stenting suggests that the use of anticoagulants such as
heparin should be avoided post-operatively to minimize the
possibility of hemorrhage.22 However, in this study heparinlk because of severe cerebral ischemia. (A) DSA showing bilateral
artery recanalization was performed successfully with visible blood
bral arteries improved signiﬁcantly.
Figure 2. Patient 2 was a 23 year old female who suffered from hemiplegia because of left carotid and subclavian artery occlusions ((A)
black arrow). Severe stenosis in the innominate artery is visible ((A) white arrow). (B) Angiography demonstrated left carotid artery patency
1 month after recanalization (white arrow).
504 B. Chen et al.was given post-operatively at a dose determined by the
activated partial thromboplastin time results. The hyperco-
agulable state, the recanalized lumen lacking endothelial
cells, and the low volume of blood ﬂow combined to in-
crease the risk of local thrombosis. Despite this, re-
occlusion by acute thrombosis occurred 3 days post pro-
cedure in one patient because of a failure to control
hypercoagulation with adequate doses of heparin and
corticosteroids.
Corticosteroids continue to be the mainstay of treatment
in TA and control of vascular inﬂammation with immuno-
suppressive treatment pre- and post-intervention has beenFigure 3. Patient 9, a 38 year old male who suffered from hemiplegia re
arrow). An ascending aorta to left carotid artery and subclavian arte
dizziness and aphasia returned when the graft thrombosed ((A) the fo
taken 6 months after successful recanalization of the left common c
common carotid artery and recanalization of the left subclavian and
maintained in the left carotid artery through 26 months of follow up
months. The bypass graft also occluded (black arrows indicates the dishown to be beneﬁcial.3e5 All of the patients were given
corticosteroids and antiplatelet agents at least 2 weeks
before the operation and four patients who appeared to
have accelerating disease progression were also given
immunosuppressive agents. Surgical or endovascular treat-
ment is possible in as few as 20% of patients with TA, but
these patients suffer severe vessel stenosis or occlusion
with impending organ ischemia, and prompt revasculariza-
tion procedures are needed. Persistent inﬂammation at the
site of intervention seems to be responsible for re-stenosis
or re-occlusion post-operatively. Therefore, successful
treatment should be followed by strict control of systemicsulting from left carotid and subclavian artery occlusions ((A) white
ry bypass had been performed 4 years previously. Symptoms of
ur way arrow indicates the stump of the graft). (B) An angiogram
arotid artery showing continued patency. Angioplasty of the left
left vertebral arteries was performed four times. Patency was
(white arrow) but the left subclavian artery re-occluded after 6
stal anastomosis of the occluded bypass).
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quently. In the cases described here, steroid dose was
determined in consultation with an immunologist and
adjusted according to symptoms.
Finally, as TA is rare, it is difﬁcult to accumulate large
numbers of patients with severe cerebral ischemia in a
single center and therefore sample size was limited. Also, as
all the patients described were of low economic status, and
for at least four of them the illness had exhausted their
ﬁnancial resources, this could negatively affect the conti-
nuity of treatment. Lack of available literature on such an
approach limited our exchange of information with others.
CONCLUSION
Type I TA patients often suffer from severe cerebral
ischemia which requires revascularization to prevent a
catastrophic outcome. When combined with strict immu-
nosuppressive treatment, endovascular surgery for carotid
artery revascularization is an effective, repeatable, and safer
therapeutic alternative than open surgery, especially in
patients with acute phase disease with critical ischemia.
Maintaining patency of the recanalised carotid artery and
improving carotid artery blood ﬂow relieves symptoms of
cerebral ischemia and helps sustain quality of life (See
Figs. 1e3).
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